MannKind Corp
MNKD
#5928
Rank
โ‚น121.21 B
Marketcap
โ‚น376.98
Share price
-2.71%
Change (1 day)
-25.52%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -โ‚น6.50

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น6.68. In 2025 the company made an earnings per share (EPS) of โ‚น1.91 a decrease over its 2024 EPS that were of โ‚น9.54.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น6.50-440.4%
2025โ‚น1.91-80%
2024โ‚น9.54
2022-โ‚น32.456.25%
2021-โ‚น30.5428%
2020-โ‚น23.86-7.41%
2019-โ‚น25.77
2017-โ‚น105.94-188.1%
2016โ‚น120.25-128.31%
2015-โ‚น424.7074.51%
2014-โ‚น243.37-20.31%
2013-โ‚น305.40-32.63%
2012-โ‚น453.33-28.03%
2011-โ‚น629.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.02-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น409.94-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,694-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น341.18-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น278.68-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น803.59 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA